Stroke & Vascular Disorders
TIAs (vertebrobasilar)
Mar. 09, 2023
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Worddefinition
At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium voluptatum deleniti atque corrupti quos dolores et quas.
Infarcts in the distribution of the basilar artery are perhaps the most feared and devastating of all ischemic strokes. However, an important proportion of patients can have good outcomes, especially with time-sensitive treatment approaches. This article reviews four distinct syndromes of basilar artery stroke, including proximal and middle basilar artery occlusions, top of the basilar artery syndrome, basilar artery branch occlusions, and dolichoectasia of the basilar artery. Pertinent vertebral and basilar artery anatomy and physiology are discussed. Potential causes of posterior circulation ischemic stroke are highlighted. Emerging assessment and treatment strategies for acute basilar artery occlusion and strategies for prevention of recurrent basilar artery stroke are reviewed. Finally, pediatric ischemic stroke in the posterior circulation and intravenous thrombolytic use in children and during pregnancy are also discussed.
• Basilar artery stroke can be a grave condition. | |
• Basilar artery stroke is most commonly caused by atherothrombosis and cardioembolism. | |
• Patients with acute ischemic stroke in the basilar artery territory should receive intravenous alteplase, also referred to as tPA, if they qualify according to accepted criteria. | |
• Patients with large vessel occlusion of the basilar artery should be considered for endovascular thrombectomy, although definitive evidence is lacking from randomized controlled trial data. | |
• Optimal treatment for patients with dolichoectasia of the basilar artery is uncertain. |
The first clinico-pathologic report of basilar artery occlusion appeared in 1868 by Hayem (65). In 1882, Leyden reviewed prior cases of basilar artery occlusion, reported 2 additional clinico-pathologic cases of his own, described aneurysmal dilation of the basilar artery, and discussed the differential diagnosis between atherosclerotic basilar artery disease and superimposed thrombosis, embolism to the basilar artery, and syphilitic basilar artery endarteritis with thrombosis (86). His discussion of 3 patients who presented with sudden (but nonfatal) bulbar signs, presumed to have basilar artery thrombosis, probably represents the first recorded instance of basilar artery stroke. Charles Dana, in an extensive review of infarctions and hemorrhages of the pons and medulla surveyed 39 autopsied cases of lower brainstem infarction and noted that many patients had prodromal transient attacks of hemiparesis, vertigo, dysarthria, and double vision during the months or years preceding their major strokes (36). He divided the clinical presentation into 2 major categories: (1) long tract motor and sensory dysfunction and (2) bulbar symptoms and signs. Foix and Hillemand published a detailed review of pontine infarcts and the anatomy of the basilar artery and its branches (53).
Kubik and Adams' classic report on basilar artery occlusion in 1946 shaped modern conceptions of pathology and pathogenesis of basilar artery steno-occlusive disease (76). They analyzed 18 necropsy cases, concluding that basilar artery occlusions are characterized by frequent early loss of consciousness, common bilateral involvement, and combinations of pupillary disturbance, ocular and other cranial nerve palsies, dysarthria, Babinski signs, hemiplegia or quadriplegia, and often a marked remission of symptoms. Biemond emphasized amnesia, hemianopsia, and other posterior cerebral artery manifestations of basilar artery distribution ischemia (20). Millikan and Siekert detailed vertebrobasilar transient ischemic attacks ("vertebrobasilar insufficiency") and advocated anticoagulants as therapy. Kemper and Romanul described a patient with the loss of the ability to communicate due to limb and bulbar paralysis, a condition later coined "locked-in syndrome." A public light was shed on this rare and devastating disorder with the 1997 publication and film of the same name in 2007, Le Scaphandre et le Papillon (The Diving Bell and The Butterfly) a moving, first-person account by Jean-Dominique Bauby, former Editor-in-Chief of the French magazine Elle and a victim of a basilar artery stroke. The locked-in syndrome had already been depicted in Alexandre Dumas’ novel The Count of Monte Cristo, when he created Monsieur Noirtier de Villefort. Dumas described his character as a “corpse with living eyes” (151). Caplan described the "top of the basilar syndrome” and attributed it to embolic occlusion of the distal basilar artery producing ischemia of the rostral brainstem and the posterior cerebral artery territories (30).
The clinical manifestations of basilar artery ischemia vary according to the site and nature of vascular compromise. Four broad clinical profiles may be distinguished.
Proximal and middle basilar artery occlusive disease. Stenosis or occlusion of the proximal or middle segments of the basilar artery is frequently atherosclerotic in origin. It produces unilateral or bilateral pontine dysfunction and less often cerebellar, midbrain, occipital, or mesial temporal lobe ischemia. The clinical profile of large vessel pontine ischemia is dominated by long tract motor dysfunction, frequent altered consciousness, and disordered horizontal eye movement.
The most characteristic motor manifestation is asymmetric quadriparesis, though hemiparesis, hemiplegia, and quadriplegia can occur. Weakness of bulbar musculature, including the face, pharynx, larynx, and tongue, is frequent and typically bilateral. A crossed pattern of motor deficit occasionally is encountered, for example, simultaneous lower motor neuron left facial weakness and upper motor neuron right arm and leg paresis. Bulbar symptoms include facial weakness, jaw weakness, dysarthria, dysphonia, and dysphagia. Impaired handling of secretions with aspiration is a common complication. The most extreme motor manifestation of pontine ischemia is the locked-in syndrome; this is characterized by complete loss of all voluntary limb and facial movement, with retained consciousness and preserved vertical gaze. Basilar artery thrombosis may also present as a transient locked-in syndrome (54).
Oculomotor signs include a sixth nerve palsy, horizontal gaze paresis, internuclear ophthalmoplegia, the one-and-a-half syndrome (ipsilateral horizontal gaze palsy in 1 direction of gaze and internuclear ophthalmoplegia in the other), ocular bobbing (rapid downward movement of the eyes with slow return to primary position), horizontal nystagmus, vertical nystagmus, ptosis, and skew deviation. Pupils are often spared, but pinpoint, reactive pupils may be seen in comatose patients with large pontine lesions.
Acutely altered consciousness is present in up to half of patients with proximal-middle basilar artery occlusions. Findings range from mild somnolence to coma.
Less prominent manifestations of proximal-middle basilar artery territory ischemia include limb ataxia, pseudobulbar affect, somatosensory deficits, and hemianopsia. Limb ataxia occurs frequently, is often bilateral, and usually coexists with, but is disproportional to, homolateral weakness. Pathologic crying and laughing appears occasionally. Unilateral or bilateral somatosensory deficits are reported in one-fifth of patients. Occasionally, artery-to-artery embolism from the proximal basilar artery to the posterior cerebral artery produces homonymous hemianopsia, visual agnosia, memory dysfunction, and other features of occipital or mesial temporal lobe ischemia. Basilar artery ischemia can manifest as acute unilateral or, more rarely, bilateral sensorineural hearing loss (74) or rhythmic tonic movements of all the extremities, often mistaken as seizures (125; 152).
Transient vertebrobasilar circulation ischemic attacks precede stroke in about three fourths of infarcts due to proximal and middle basilar artery stenosis or occlusion. Often 1 or more transient ischemic attacks culminate in infarction over a 3- to 6-month time period. Occasional patients may have transient ischemic attacks alone, or incidental, asymptomatic disease. Infarcts often progress with a stuttering course of stepwise worsening over minutes, hours, or days, although abrupt onset of maximal deficit can occur.
Basilar artery thrombosis may cause auditory hallucinations. Galtrey evaluated a 60-year-old man with episodes of bilateral auditory hallucinations described as “white noise,” which were associated with basilar artery thrombosis and attributed to ischemia of the auditory pathways in the brainstem (55).
Distal basilar artery occlusive disease ("top of the basilar syndrome"). Occlusion of the distal basilar artery is frequently embolic in origin, and produces signs of midbrain and thalamic ischemia, occipital and mesial temporal lobe ischemia, or both.
Infarction of the rostral brainstem and cerebral hemispheres fed by the distal basilar artery causes a clinically recognizable syndrome characterized by visual, oculomotor, and behavioral abnormalities, often without significant motor dysfunction. Leading features of midbrain ischemia are abnormalities of oculomotor and pupillary function and alertness.
Somnolence, vivid hallucinations, and dreamlike behavior can also accompany rostral brainstem infarction. Temporal and occipital lobe infarctions frequently cause hemianopsia with distinctive characteristics, fragments of the Balint syndrome named for the Austro-Hungarian neurologist Rezso Balint in 1909 (a triad of optic ataxia, oculomotor apraxia, and simultanagnosia), amnesia, and agitated behavior. More than three fourths of patients exhibit disruption of voluntary and reflex vertical gaze, rarely selectively affecting upgaze or downgaze but more often disrupting both. Convergence abnormalities are common, most often esotropia at rest or convergence retraction nystagmus (quick phases that converge or retract the eye) on attempted vertical gaze. Bilateral eyelid ptosis and lid retraction occur. Pupils will be fixed and dilated if the third nerve nucleus is compromised. Hypersomnolence may be present at onset, and rarely can persist for months. Ataxia occurs frequently, but hemiparesis is rare. Visual hallucinations, vivid but generally nonthreatening, are infrequently observed ("peduncular hallucinosis") (30).
When ischemia extends to the mesial or anterior thalamus, memory dysfunction, abulia, or both, may appear.
Occipital lobe infarction produces visual field defects, generally homonymous hemianopsia or homonymous quadrantanopsia. Alexia without agraphia may appear with dominant occipital lesions involving the splenium of the corpus callosum. Bilateral lesions may produce other higher visual function disturbances, including cortical blindness, prosopagnosia, visual object agnosia, and Balint syndrome. Mesial temporal lobe infarction can produce memory disturbance, especially if lesions are bilateral (110). Agitated delirium at onset can occur with dominant occipitotemporal infarcts.
Transient ischemic attacks commonly precede strokes when distal basilar artery disease is due to local and upstream atherosclerosis within the vertebrobasilar system, whereas embolism from the heart and ascending aorta usually produces sudden infarcts without warning.
Generalized tonic clonic seizures may rarely be the initial presentation of the top of the basilar syndrome (96).
Basilar branch disease. Occasionally, basilar artery atherothrombosis may occlude the ostium of a penetrating vessel without compromising flow in the basilar artery itself, producing a fractionated ventral pontine clinical syndrome. Ataxia, hemiparesis, and dysarthria in various combinations are common, including syndromes of pure motor hemiparesis, ataxic-hemiparesis, and clumsy hand-dysarthria. Either vertigo or diplopia appears infrequently, accompanying mild, transient sensory loss.
Basilar artery dolichoectasia (elongation and tortuosity). When the basilar artery becomes markedly widened, elongated, and tortuous, distinctive syndromes related to compression may arise in addition to ischemic syndromes related to abnormal laminar flow causing thrombosis and occasional distal embolism, torsion occluding the origins of small penetrating vessels, and associated intrinsic small vessel disease (37). Cranial nerve compressive signs are present in over half of symptomatic cases, most often hemifacial spasm and trigeminal neuralgia. It can also cause abducens nerve (CN VI) paralysis, and rarely compress the optic tract, accounting for optic atrophy and homonymous hemianopsia. Direct brainstem compression of the ventral pons may produce ataxia and hemiparesis, progressing over months to years. Hydrocephalus may arise and produce gait, bladder, and cognitive abnormalities. Headaches occur in 15%. Almost half of reported symptomatic cases have coexisting or isolated ischemic symptoms, affecting pontine, midbrain, cerebellar, thalamic, or occipitotemporal regions. Subarachnoid hemorrhage can occur infrequently. In younger people, dolichoectasia may be associated with acquired immune deficiency syndrome (AIDS), Marfan syndrome, Ehler-Danlos syndrome, sickle cell disease, autosomal dominant polycystic kidney disease, neurofibromatosis type I, pseudoxanthoma elasticum, tuberous sclerosis complex, Pompe disease, moyamoya disease, cavernous malformations, and Fabry disease (92; 37). Ischemic symptoms are often attributable to lacunar infarctions. Apart from symptomatic cases, dolichoectatic basilar arteries are often an asymptomatic finding at imaging or autopsy.
Series of patients diagnosed by noninvasive imaging suggest a less ominous prognosis than earlier autopsy and angiographic cohorts, but basilar artery stroke remains a grave condition. One review found that patients presenting with consciousness disorders or the combination of dysarthria, pupillary disorders, and lower cranial nerve involvement invariably had poor outcomes compared to only 11% of patients without these signs (40). In addition, patient age and comorbidity, the size of infarct, and whether the vascular lesion is stenotic or totally occlusive are major determinants of outcome.
Prospective data on acute outcome from basilar artery stroke are sparse. In the New England Medical Center Registry series of 87 patients with severe basilar artery occlusive disease, only 2.3% of patients died of their acute stroke. At hospital discharge 40% had no neurologic deficit, whereas residual deficits were minor in 31%, and severe in 26%. Predictors of poor outcome included distal territory involvement, embolism, occlusion, impaired consciousness, tetraparesis, and abnormal pupils. Similarly, in a series of 27 patients with top of the basilar stroke, only 4% died within the first 30 days (104).
The typical course of basilar artery occlusions is more devastating than basilar artery stenoses. Angiographic series have reported mortality in 80% to 90% of patients. (79; 63; 49). Other studies suggest a less grim prognosis, especially in patients with atherothrombotic occlusions of only a short basilar segment and good collateral supply (78; 26). Endovascular therapy may improve the outcome of acute basilar artery occlusion.
There is a paucity of long-term follow-up information regarding patients who suffer from locked-in syndrome. Five-year survival rates have been estimated to be 80%, and some patients have been reported to live for more than 20 years. In an attempt to further understand locked-in syndrome, 44 patients surviving an average of 62 months following onset of locked-in syndrome were surveyed (84). Attention level was described as good by 86%, and 77% were able to read. A majority (85%) characterized themselves as being more emotional than before their stroke, and 48% reported a good mood. Although communication is difficult for patients with locked-in syndrome, 66% could communicate without technical aids using a system of eye movements and blinking, and 78% were capable of emitting sounds. This survey highlights the importance of multidisciplinary treatment of patients with locked-in syndrome in order to maximize their abilities. In another study of 67 patients with locked-in syndrome for a median of 7 years, including 51 due to stroke, self-reported quality of life survey results were relatively satisfactory compared to those with other severe conditions. Satisfaction persisted during a 6-year follow-up interval. However, those whose communication was limited to yes-no code rather than an electronic communication device reported lower satisfaction (122).
Patients with basilar artery embolism with spontaneous dissolution may fare better than those with persistent occlusion. In a study of patients with presumed basilar artery embolism without occlusion, 42% had no or only mild neurologic deficits 8 to 12 weeks after stroke onset, and 18% died (130).
The long-term risk of recurrent transient ischemic attack or stroke after first ischemic presentation of basilar artery disease is poorly defined. Anecdotal clinical experience suggests that intrinsic atherothrombotic disease is attended by frequent subsequent transient ischemic attacks or recurrent strokes. In the Oxford Vascular Study, the 90-day risk of recurrent stroke or transient ischemic attack was 46% for patients with greater than or equal to 50% basilar or vertebral artery stenosis (95). Distal basilar artery low flow status as measured by quantitative MRA in patients with at least 50% symptomatic stenosis of the vertebral or basilar arteries within the preceding 60 days is strongly associated with subsequent stroke risk (06). Moreover, despite the overall increased stroke risk with higher blood pressure in patients with intracranial stenosis, blood pressure 140/90 mm Hg or lower may increase the stroke risk in patients with symptomatic vertebrobasilar stenosis and low-flow status (07).
Nearly half of patients with basilar artery dolichoectasia deteriorate clinically over 5-years (155). Infarction (18%), transient ischemic attack (10%), compressive symptoms (10%), intracerebral and subarachnoid hemorrhage (6%), and hydrocephalus (3%) account for the clinical deterioration (37). Those with large, bilateral pontine infarcts related to basilar artery occlusion almost uniformly experience poor outcomes. Those with smaller, unilateral pontine infarcts, likely due to obstruction of the origin of a pontine penetrator or associated intrinsic small vessel disease, have a more favorable early outcome. The long-term course is poor, with up to one third of patients dying within 5 years, often from recurrent stroke (98). Symptomatic initial presentation, dolichoectasia severity at diagnosis, worsening angioarchitecture during follow-up and mural thrombus, contribute to delayed morbidity. Radiographic progression occurs in 42%.
Complications of basilar artery stroke include aspiration, dysphagia requiring G-tube or J-tube placement, urinary tract infection, pressure ulcers, and venous thromboembolism.
Vignette 1. A 65-year-old man with arterial hypertension, hypercholesterolemia, and coronary artery disease, was admitted with transient dysphagia, dysarthria, binocular diplopia, and impaired consciousness from which he markedly improved on arrival to the emergency room. He had mild dysarthria on examination at 1 hour after fluid resuscitation and blood pressure support for hypotension, which was thought to be responsible for his presentation.
A code was called later the first night of admission (12:34 am) at which time he was found unresponsive and profoundly hypertensive, tachycardic, and tachypneic.
The patient was intubated and transferred to the intensive care unit on intravenous antihypertensive agents. Evaluations for cardiac etiology and pulmonary embolism were unremarkable. Neurology consultation was obtained when patient examination did not improve by the morning. MRI of the brain demonstrated restricted diffusion in the pons. MRA demonstrated thrombus in the mid-basilar artery. Endovascular treatment was unsuccessful. The patient remained in a “locked-in” state and mechanical ventilation was eventually withdrawn at his own wish.
Vignette 2. A 65-year-old woman presented with acute onset ataxia, headaches, bilateral arm numbness, and binocular diplopia. Examination was remarkable for decreased alertness, bilateral sixth nerve palsies, and bilateral upper limb dysmetria. Further deterioration in her level of consciousness prompted an acute CT without contrast, which was normal. MRI showed restricted diffusion in bilateral thalamic, bilateral cerebellar, and right midbrain regions. Presentation after 3 hours prompted catheter cerebral angiography where basilar artery thrombus superior to the anterior inferior cerebellar artery branches was demonstrated. Intraarterial tissue plasminogen activator (tPA) in combination with MERCI (Mechanical Embolectomy Retrieval in Cerebral Ischemia) retriever restored flow to the remainder of posterior circulation with good clinical outcome. (Courtesy of Dr. Tim Malisch and Dr. José Biller.)
Vignette 3. An 81-year-old woman with arterial hypertension and a left middle cerebral artery bifurcation aneurysm was evaluated at an outside hospital for nausea, dysarthria, headache, and dizziness. She was intubated after exhibiting decreased alertness in the emergency department. Gaze-evoked nystagmus, decreased arousal, and inability to follow commands were noted on examination prior to intubation. She was transferred to our institution for further evaluation and management. MRI and MRA showed right cerebellar, midbrain, bilateral occipital, and pontine tegmentum infarcts from proximal basilar artery thrombosis. (Courtesy of Dr. José Biller.)
Vignette 4. A 51-year-old man was evaluated for transient quadriparesis and dysarthria. At the time of examination, the patient was asymptomatic with unremarkable neurologic exam. He had a history of prior transient right hemiparesis. Diffusion-weighted MRI showed no acute lesion. MRA demonstrated moderate to severe midbasilar artery stenosis. Catheter cerebral angiography showed a 65% to 70% midbasilar stenosis with poststenotic dilatation above the level of the anterior inferior cerebellar artery and below the labyrinthine arteries. (Courtesy of Dr. José Biller.) The patient was placed on antiplatelet and statin therapy.
Vignette 5. A 69-year-old man with diabetes mellitus, arterial hypertension, and a previous stroke was found unconscious at home. He was last known to be well 8 hours before. His trachea was intubated on the scene by Emergency Medical Services and he was taken to the emergency department. Initial neurologic exam was confounded by residual pharmacologic paralysis and sedation used for intubation. Emergent CT showed a midbasilar hyperdensity suggesting thrombus and MRI demonstrated restricted diffusion in bilateral cerebellar, bilateral thalamic, and bilateral occipital regions. Follow-up examination showed impaired consciousness, bilateral decerebrate posturing, bilateral nonreactive pupillary reflex, bilateral absent corneal reflex, absent eye movements with oculovestibular reflex testing, and preserved gag reflex.
Vignette 6. A 70-year-old man with a past history of trigeminal neuralgia awoke with dysarthria, left hemiplegia, and nausea. Examination also revealed horizontal and vertical nystagmus, skew deviation, and hoarse voice. Noncontrast brain CT showed hyperdensity anterior to the pons consistent with dolichoectasia of the basilar artery with acute or chronic thrombus. CT angiography demonstrated dolichoectasia of the basilar artery with occlusion of bilateral vertebral arteries and proximal basilar artery. MRI showed displacement of the brainstem with restricted diffusion in the right pons consistent with paramedian pontine small vessel distribution infarction. Motor examination initially improved to antigravity strength in the left arm and leg. Non-bolus intravenous heparin nomogram was started on hospital day 1 with target aPTT 50 to 70. He was transitioned to subcutaneous enoxaparin 1 mg/kg twice daily on hospital day 2, and warfarin was initiated. On hospital day 4, he became acutely unresponsive, apneic, bradycardic, and pulseless. A code was called, trachea was intubated, and return of spontaneous circulation was achieved. Noncontrast brain CT demonstrated diffuse subarachnoid hemorrhage. Neurologic examination did not recover, and death was subsequently declared by neurologic criteria.
Atherothrombosis and cardioembolism are the most common causes of basilar artery territory infarctions. Less frequent etiologies include cervicocephalic vertebral artery dissection, migraine, dolichoectasia, hematologic disorders (eg, sickle cell disease, hypercoagulable states), vasculitis, meningovascular syphilis, and paradoxical embolism (97; 156).
Anatomy. The vertebral arteries unite to form the basilar artery at the base of the pons. The vertebral arteries arise from their respective subclavian arteries medial to the anterior scalene muscle. After originating (ie, V1 or first segment) from the subclavian arteries, the vertebral artery traverses the foramina transversaria from C6 to C2 (ie, V2 or second segment), loops around the atlanto-occipital joint (ie, V3 or third segment), and finally pierces the dura passing through the foramen magnum to enter the intracranial cavity (ie, V4 or fourth segment) to join the other vertebral artery at the pontomedullary junction. The V2 segment is further subdivided into proximal V2 segment (C6), mid V2 segment (C2-5), and distal V2 segment (C1-2). The basilar artery ascends in a shallow groove on the anterior surface of the pons, with an average length of 32 mm and width of 2.6 mm to 3.5 mm (126). In most patients, the artery is curved, whereas in one fourth of patients it follows a straight-line rostral course. The basilar artery ends by dividing into the 2 posterior cerebral arteries in 80% of the population at the level of the interpeduncular cistern. Many variations can occur, including fetal origin of 1 or both posterior cerebral arteries, a vertebral artery ending as a posterior inferior cerebellar artery, and a persistent trigeminal artery. Asymmetric vertebral arteries are found in over two thirds of cases. Throughout its rostral course in the middle third, the basilar artery gives off approximately 14 small paramedian branches that penetrate directly into the ventral pons and lower midbrain, and 14 small circumferential arteries that loop around the pons and midbrain to give off lateral basal and lateral tegmental penetrators (123; 108).
The major branches of the posterior circulation include the paired posterior inferior cerebellar arteries, which arise from the V4 segment and can have intra- or extradural origins in some cases. Paired anterior inferior cerebellar arteries arise next from the more proximal basilar artery. Distal paired superior cerebellar arteries arise last, prior to the basilar artery termination into bilateral posterior cerebral arteries, and serve the superior cerebellum. Clinically, superior cerebellar artery territory infarcts can potentially interrupt Mollaret’s triangle and cause palatal tremor (myoclonus).
The pons is a knob-like process measuring approximately 2 cm in length. It is organized into white matter tracts that travel transversely whereas most other fibers in the brainstem travel rostral and caudal. The posterior surface of the pons forms the anterior wall of the fourth ventricle. The pons may be further subdivided into the basis pontis and pontine tegmentum.
The basis pontis or anterior portion of the pons houses the corticospinal tracts and the nuclei of cranial nerves V, VI, VII, and VIII. The mid-pons houses the motor nucleus and chief sensory nucleus of cranial nerve V. The lower pons houses the cranial nerve nuclei VI, VII, and VIII. Corticopontine fibers carry signals from the primary motor cortex to the ipsilateral pontine nuclei in the anterior pons. Pontocerebellar fibers then relay information to the contralateral cerebellar hemispheres, allowing action modification and correction in complex motor activities. The pons also controls arousal and regulates respiration. The pontine tegmentum located more posteriorly is involved in sleep and wakefulness and is postulated to be involved in initiation of REM sleep. It contains the richly serotonergic raphe nucleus and locus coeruleus, a norepinephrine-producing area involved in stress response and anxiety. Tegmental lesions in various models can reduce or eliminate REM sleep and dreaming.
Basilar artery fenestration (BAF), considered a normal anatomic variant, has been reported in association with arteriovenous malformations and developmental arterial anomalies (11). Basilar artery fenestration has a reported prevalence of 1.5% and may play a role in basilar aneurysmal formation and basilar artery thrombosis (17).
Atherosclerosis. Atherothrombotic disease is the most common cause of basilar artery strokes. In a series of 87 consecutive cases of basilar artery ischemia, atherothrombotic disease accounted for approximately 86% (145). Among intracranial vessels, the basilar artery is a frequent site of atherosclerotic change. The middle and proximal thirds of the basilar artery are more susceptible than the distal segment but the difference is slight. In a review of 412 reported cases of basilar artery atherostenosis, the middle portion was involved in 56%, the proximal in 48%, and the distal in 40% (31). Patterns of vessel injury included atherosclerosis confined to the basilar artery, complex plaques arising in a distal intracranial vertebral artery extending into the basilar artery, and diffuse, disseminated vertebral and basilar artery atherosclerosis.
Embolism. Embolism to the basilar artery is the second most common cause of basilar artery territory strokes, responsible for 14% of cases in one series (145). Emboli lodging in the basilar artery generally produce acute occlusion rather than stenosis. Origins for the emboli include the heart, atherosclerotic lesions of proximal extracranial and intracranial vertebral arteries, proximal subclavian arteries, the aortic arch, and vertebral artery dissection. Because the width of the basilar artery narrows as it courses distal, most emboli small enough to pass through the vertebral arteries will traverse the proximal basilar segment and occlude the middle or distal segments.
Cervical spine surgical interventions including reduction of cervical spondylolisthesis can rarely result in distal vertebrobasilar embolization (141).
Dolichoectasia. The basilar artery and the distal vertebral arteries, along with the internal carotid arteries, are particularly susceptible to a dilatative arteriopathy, producing dolichoectasia (dolichos meaning “long”, ectasia meaning “distended”), also called “fusiform aneurysm” (92). Various theories for the development of basilar and carotid dolichoectasia have been advanced, including congenital defects of the media or internal elastic laminae; and unrecognized preceding arterial dissection with formation of dissecting aneurysms (09). Some or all of these mechanisms likely operate together to account for most cases. Although atherosclerosis can be found within dolichoectatic vessels and atherosclerotic degeneration was previously proposed as a cause, it is now well-accepted that infarction associated with dolichoectasia occurs by independent mechanisms. Concomitant small vessel arteriopathy is commonly found. Symptoms result from cranial nerve (most frequently the facial and trigeminal nerves) or brainstem compression; ischemia due to thrombus formation within the ectatic vessel or torsion of basilar artery penetrators, and rarely vessel rupture, producing subarachnoid hemorrhage.
Bow hunter syndrome. Bow hunter syndrome is a rare condition whereby lateral head rotation produces symptoms of vertebrobasilar ischemia by mechanical compression of a vertebral artery. The term was coined by Sorensen in 1978, who described a patient who developed a Wallenberg syndrome during archery practice (136). Symptoms include syncope or presyncope, vertigo, diplopia, nystagmus, hemiparesis, paresthesias, nausea and vomiting, Horner syndrome, dysphagia, and headache. Symptoms may be transient or persistent due to ischemic stroke in cases of sufficient hemodynamic compromise or formation of thromboembolism.
A case series of 11 patients diagnosed by dynamic catheter-directed vertebral angiography over 14 years at a tertiary referral center reported that the level of vertebral artery compression was most commonly C1-2 and C5-7, with a slight predilection for the left vertebral artery (159). In the same study, the direction of head rotation did not predict the laterality of the compressed artery; 55% of patients had compression contralateral to head rotation, whereas 45% had ipsilateral symptoms. Surgical decompression may be beneficial in alleviating symptoms, although clinical trial data are lacking.
Cerebral vasculitis and other miscellaneous etiologies. Rare causes of basilar artery thrombosis include meningovascular syphilis, Behçet disease, antiphospholipid syndrome, meningitis, giant cell arteritis, and neuroborreliosis. Back and colleagues reported 11 patients with neuroborreliosis-associated cerebral vasculitis (12). Eight cases involved the vertebrobasilar circulation, and 2 had basilar artery thrombosis.
Posterior circulation infarcts represent 12% to 27% of all strokes in hospital-based registries, and basilar artery disease accounts for a substantial proportion of these (23; 24). Among 520 consecutive patients with posterior circulation ischemia in 3 series, basilar artery stenosis or occlusion was responsible for 20% (22; 31). These data suggest that basilar artery stenosis or occlusion is responsible for approximately 4% of all infarcts.
Well-established systemic vascular risk factors strongly influence the development of atherosclerotic change. In the New England Medical Center series of 66 consecutive patients with basilar artery atherostenosis, hypertension was present in 64%, diabetes in 36%, tobacco use in 35%, hyperlipidemia in 35%, coronary artery disease in 45%, and peripheral vascular disease in 20%. Affected individuals tend to be over the age of 50, and more men are reported than women. People of African descent, and possibly those with Asian ancestry, have a predilection to stenosis in more distal segments of the basilar artery, whereas Caucasians are predisposed to stenosis in more proximal segments (59; 31).
Atrial fibrillation is the most common risk factor for cardioembolism to the basilar artery. Valvular disease, left ventricular dysfunction, and patent foramen ovale are also important. Acute basilar artery occlusion is an infrequent complication of cardiac papillary fibroelastoma (91).
Dolichoectasia of the basilar artery is increasingly encountered. Older autopsy and angiographic series of consecutive cases estimated an incidence greater than 0.1% (68; 66; 158). An MRI study identified dolichoectatic vertebrobasilar arteries in 0.9% of 1416 consecutive patients (129). However, in clinical series of patients with posterior circulation ischemia, vertebrobasilar dolichoectasia is present in 3% to 14% of cases (22; 31). In a population-based study of patients with first ischemic stroke, 2.5% had a dolichoectatic basilar artery (71). In a multiethnic study of stroke-free patients older than 55 years, at least 1 dolichoectatic intracranial artery was found in 19% (62). Risk factors for dolichoectasia of the basilar artery include increasing age and male sex, with an average age at diagnosis of 59 years, and men accounting for approximately 70% of reported cases (85). Risk factors for stroke occurrence include more severe ectasia and vertical elongation and superimposed atherosclerosis (113).
Primary prevention of atherosclerotic disease of the basilar artery includes long-term control of established vascular risk factors. Tobacco abstinence and management of arterial hypertension, diabetes, and hyperlipidemia should be pursued according to standard guidelines. Primary prevention of cardioembolism to the basilar artery should also follow standard guidelines. In patients with atrial fibrillation, anticoagulation with warfarin with a target international normalized ratio of 2.0 to 3.0 or a direct oral anticoagulant such as a direct thrombin inhibitor or anti-Xa agent should be employed if the patient has no major contraindication to anticoagulation and if there is also a history of hypertension, diabetes, coronary artery disease, prior transient ischemic attack or stroke, or if the patient is over age 75. Younger patients with lone atrial fibrillation may adequately be treated with aspirin at a dose of 325 mg daily.
Basilar artery disease is most closely mimicked by other illnesses that cause brainstem pontine dysfunction. These include brainstem encephalitis, demyelinating disease, central pontine myelinolysis (osmotic demyelination syndrome), and basilar migraine.
Basilar artery stroke can also mimic a host of other conditions, leading to a missed diagnosis of basilar artery stroke. These include other causes of acute coma or depressed levels of consciousness. Distal basilar artery occlusion may result in top of the basilar syndrome, which can present with acute neuropsychiatric abnormalities, including visual disturbances and hallucinations that may be confused with psychiatric disease. Basilar artery occlusion may present with rhythmic movements of the extremities mimicking convulsive seizures (152). Clues to basilar artery ischemia include abrupt onset, the presence of a Parinaud syndrome, Collier sign (retraction and elevation of the eyelids), pupillary abnormalities indicating midbrain involvement, and vertical gaze paresis.
Infectious rhombencephalitides tend to have slower onset over hours to days, be accompanied by fever, follow infectious exposures, and have a marked cerebrospinal fluid pleocytosis. Multiple sclerosis tends to have slower onset over hours, history of prior lesions disseminated in time and space, lesions confined to white matter, and cerebrospinal fluid positive for oligoclonal bands, and elevations in IgG synthesis and index ratio. The clinical differentiation of both disorders from basilar artery ischemia is sometimes challenging as basilar artery atherosclerotic disease produces abrupt, maximal onset of deficits less often than ischemia at other sites, and a stuttering, progressive course over hours to days is not unusual. Central pontine myelinolysis tends to follow episodes of rapid correction of hyponatremia or other systemic illness, and produces bilateral tegmental lesions not fully respecting vascular territory boundaries. Migraine with brainstem aura (previously known as basilar-type migraine) tends to occur in younger adults, often children, and usually produces transient episodes of posterior circulation territory dysfunction (dysarthria, vertigo, diplopia, ataxia, tinnitus, visual symptoms, simultaneous bilateral paresthesias, decreased level of consciousness, etc.) lasting 20 to 30 minutes. The diagnostic picture can be mixed as migraine can rarely be associated with basilar artery stroke, and ischemia related to basilar artery disease can precipitate headaches.
Occasional patients with bilateral intracranial vertebral artery stenosis will experience pontine ischemia due to hemodynamic impairment or artery-to-artery emboli, mimicking intrinsic basilar artery disease.
Additionally, a number of other metabolic or systemic etiologies for basilar stroke must be considered. These include trauma leading to vertebral or basilar pseudoaneurysm or dissection with subsequent thrombus formation, cardioembolic sources, vasculitides, hypercoagulable states, Fabry disease, and sickle cell disease. Screening may involve rheumatologic investigation including sedimentation rate, C-reactive protein, antiphospholipid syndrome panel, antinuclear antibodies, rheumatoid factor, ANCA, CSF analysis, or more detailed hypercoagulable studies.
Analysis of clinical features of patients who present with posterior circulation ischemia show commonality with unilateral limb weakness (81.9%), central facial palsy (61.1%), dysarthria (46.3%), and dizziness (33.8%) (131). The incidence of crossed paralysis was relatively low (2.8%).
Pontine syndromes as rare as inappropriate laughter or “fou rire prodromique” have been described, as well as anosognosia for hemiplegia, blepharospasm, brief jerking movements, jaw dystonia, bilateral deafness, trunk ataxia without limb ataxia, hypoesthesias, painful Horner syndrome, sleep disturbances, and trigeminal neuralgia (27).
Symptoms and signs | Vertebrobasilar artery territory |
Motor deficits | Unilateral, bilateral, or shifting limb weakness; limb clumsiness or paralysis; ataxia, imbalance, or disequilibrium with or without vertigo |
Sensory deficits | Unilateral, bilateral, or shifting limb numbness, sensory loss, or paresthesias |
Speech deficits | Dysarthria* |
Visual deficits | Binocular diplopia, partial or complete blindness in both homonymous visual fields |
Adapted from: (27) |
Diagnostic evaluation is directed toward imaging the brainstem, cerebellum, and occipitotemporal regions to characterize the size and territory of the infarct, exclude stroke mimics, determine the vascular mechanism, and guide therapy.
MRI is the preferred modality for imaging posterior fossa structures. CT can be compromised by beam-hardening artifacts from the skull base. In candidates for treatment with intravenous tPA, CT can be helpful in promptly ruling out an intracerebral hemorrhage. MRI infarct patterns particularly suggestive of proximal-middle large artery basilar disease, rather than penetrator disease, are bilateral infarction in the basal or tegmentobasal pons; bilateral infarction in the brachium pontis (anterior inferior cerebellar artery territory); and upper pontine or midbrain infarction, plus anterior inferior cerebellar artery territory cerebellar or brachium pontis infarction. In patients with top of the basilar lesions, upper pontine or midbrain infarcts may coexist with unilateral or bilateral thalamic and hemispheric posterior cerebral artery infarcts. Diffusion or perfusion MRI sequences can be especially helpful in the first few hours after onset of ischemia, when findings on standard T2-weighted MR studies may be absent or subtle.
The posterior circulation Acute Stroke Prognosis Early CT score (pc-ASPECT) has been proposed as a measurement of vertebrobasilar ischemia severity. A pc-ASPECT score of 10 is normal. One point is subtracted for left or right ischemic changes in the thalamus, cerebellar hemisphere, or posterior cerebral artery territory, and 2 points are subtracted if any part of the midbrain or pons is involved (117). A pc-ASPECT score of less than 8 is considered severe.
MRI can also help distinguish basilar branch infarcts from small artery strokes (51; 140; 15). Basilar branch infarcts tend to produce unilateral ventral pontine infarcts, often larger than 1.5 cm, that extend to the pontine surface. Small artery disease tends to produce small, unilateral tegmental or ventral infarcts that do not reach the surface of the pons. Diffusion weighted MR sequences are helpful in differentiating lesions of recent onset from prior pontine lacunae or leukoaraiosis, as they can appear similar on T2-weighted sequences.
Clues to the status of the basilar artery and related vasculature can be gleaned from standard CT and MR imaging. Calcification of the basilar artery may be seen on CT, but does not correlate well with the degree of associated atherosclerosis. Unenhanced CT may show a hyperdense basilar artery before a brainstem infarct is visualized. The presence of a hyperdense basilar artery often is a strong predictor of basilar artery thrombosis if no similar intra-arterial hyperdense changes are seen in the supraclinoid carotid arteries. (58). Absence of normal basilar artery flow voids on MR may indicate occlusion or slow flow, but also may arise from other causes such as in-plane flow effects in a tortuous, but open basilar artery. In addition, a FLAIR-hyperintense basilar artery is a strong marker of occlusion and a predictor of poor outcome (56). Dolichoectasia of the basilar artery may generally be demonstrated on both standard CT and MRI axial images. The MR will show an enlarged vessel often with inhomogeneous intraluminal signal, reflecting in situ thrombus, sometimes compressing the ventral surface of the pons.
Vessel imaging studies are crucial to characterize the status of the basilar artery as, in contrast to the anterior circulation, clinical measures such as the NIH Stroke Scale have been shown to be poor predictors of vascular occlusion in the posterior circulation (67). Options include magnetic resonance angiography, transcranial Doppler sonography, CT angiography, and catheter angiography. Intracranial magnetic resonance angiography centered on the circle of Willis will demonstrate the basilar artery in its entirety, as well as the distal portions of the feeding vertebral arteries and the initial segments of the exiting posterior cerebral arteries. Magnetic resonance angiography generally correlates well with angiographic findings, but has a tendency to overestimate degree of stenosis. However, basilar artery occlusive disease appears to be more accurately characterized on MRA than vertebral occlusive disease (19). CT angiography can rapidly image the basilar, vertebral, and posterior cerebral arteries and is less susceptible to stenosis overestimation (144). Transcranial Doppler can be a useful adjunctive study to confirm magnetic resonance or computerized tomography angiography findings, or to provide some noninvasive test information in patients intolerant of MR or iodinated contrast. The depth and tortuosity of the basilar artery can make insonation difficult, and false-positive and false-negative findings can occur, limiting its utility. Transcranial Doppler is most reliable in characterizing the proximal two thirds of the basilar artery (39; 128). Administration of IV contrast agent during transcranial Doppler sonography enhances insonation of the basilar tip and increases the total length of the basilar artery identified (70; 75; 137).
Although management decisions are often based on noninvasive MRA, CTA, and transcranial Doppler studies alone, functional imaging modalities allow real-time physiologic assessment. These include CT and MR perfusion in which cerebral blood flow, cerebral blood volume, and contrast transit-time are compared to distinguish ischemic versus likely infarcted brain tissue. CT and MR perfusion studies have been well-validated in the anterior circulation. However, their utility in the posterior circulation remains uncertain. The pc-ASPECTS score applied to CT perfusion imaging demonstrated improved performance compared to use of noncontrast CT or CTA source images and may be useful in selecting patients who may benefit from endovascular thrombectomy (142). Catheter cerebral angiography continues to play a crucial diagnostic role in a selective number of patients.
ECG and echocardiography allow screening for sources of cardioembolism. For patients in whom an embolic mechanism is clinically suspected, such as those with top of the basilar syndrome, but in whom no cardioembolic source is confirmed by ECG or transthoracic echocardiography, transesophageal echocardiography with contrast may be considered. Prolonged mobile outpatient cardiac telemetry should be considered in patients with suspected atrial fibrillation, although the duration of such monitoring is a subject of controversy.
• Acute basilar artery stroke is a medical emergency. | |
• Early recognition and diagnosis are crucial for the implementation of time-sensitive treatment. | |
• Acute treatment strategies include intravenous thrombolysis and endovascular thrombectomy. | |
• Management of secondary complications is crucial and may require intensive care unit monitoring. |
General precepts of acute stroke treatment fully apply to basilar artery stroke. Acute supportive care includes correction of severe hyperglycemia and hyperthermia, administration of supplemental oxygen as needed to maintain normal oxygen saturation, intubation if the airway is threatened by bulbar weakness or altered sensorium, assessing swallowing function before oral intake is instituted, and administration of isotonic crystalloids to maintain euvolemia (116).
The common occurrence of a slowly progressive or stuttering course suggests that hemodynamic failure may be contributing to basilar artery ischemia. Regulating intravascular volume and blood pressure to improve blood flow may be useful. In general, blood pressure should not be lowered unless it exceeds a systolic pressure of 220 mm Hg or a diastolic pressure of 120 mm Hg, the patient is to be treated by intravenous tPA, or permissive hypertension acutely threatens an existing co-morbidity (eg, heart failure or concomitant myocardial infarction) (116). In select cases with a progressive or fluctuating course, cautious blood pressure augmentation may be beneficial, theoretically taking advantage of collateral pathways. However, the coexistence of active cardiovascular dysfunction (eg, left ventricular failure) may render such patients intolerant of this strategy. Admission to an intensive care unit is often warranted in the setting of profound or unstable neurologic deficits, decreased level of consciousness, hemodynamic instability, or cardiac or respiratory failure.
The natural history of basilar artery occlusion carries such a poor prognosis that acute reperfusion constitutes an important goal for the urgent management of these patients, increasing 2- to 4-fold the odds for a favorable neurologic outcome (89; 77; 61). Studies have demonstrated that failure of basilar artery recanalization is associated with a dismal prospect for favorable outcome (89). Presently, the available strategies include intravenous thrombolysis and endovascular rescue techniques (ie, intraarterial thrombolysis, endovascular thrombectomy, and angioplasty with or without stenting).
Intravenous tPA should be offered to all patients with basilar artery stroke who present within 4.5 hours of onset and who qualify for such treatment based on accepted criteria, even in older children and adolescents (21; 116). However, the reported rates of basilar artery recanalization following this approach approximate 40% to 50%, and only 20% to 40% of patients achieve a favorable neurologic outcome (89; 124; 99). Moreover, it is evident that clot burden negatively influences the effectiveness of intravenous thrombolysis. Smaller clots more commonly result in distal basilar artery occlusion and relatively better outcomes (139).
Although not FDA approved for use in ischemic stroke, tenecteplase has shown promise for achieving higher rates of rapid recanalization in basilar artery occlusion when compared to alteplase based on retrospective observational data (03). Randomized trials are needed to test this hypothesis.
The modest results from intravenous tPA in the setting of larger clot burden have fueled the need to find a better reperfusion strategy starting with the intraarterial administration of thrombolytic agents, directly at the site of occlusion. Twelve reports primarily addressing the use of intraarterial thrombolysis for basilar artery occlusion alone or in combination with other interventions have been published since 2004 (Table 2) (135; 153). They include single and multicenter series that incorporate different treatment strategies, including the use of other antithrombotic agents, thrombectomy (using various means), angioplasty, and stenting. Only one of these reports constitutes a small, randomized comparison of intraarterial thrombolysis and systemic anticoagulation (94). Although it suggested superiority of endovascular treatment, the trial had significant limitations hindering its practical utility (94). Thus, it is difficult to reach solid conclusions about the effectiveness of intraarterial thrombolysis in the treatment of basilar artery occlusion. When available data are considered in the aggregate (Table 2), the outcomes are not materially different from those reported for intravenous thrombolysis. However, caution is advised as the available data quality may represent a type II error in reaching such a conclusion.
Reference | Series Type | Treatment Modalities | Patients (n) | Mean Age (years) | Recanalizationa (%) | Favorable outcomeb,c (%) | Mortalityc (%) | Treatment Time (min) |
(10) | Single | IAT | 40 | 58 | 80 | 35 | 43 | 330 |
(94) | Multi | IAT | 8 | 64 | – | 50 | 50 | 750 |
(16) | Single | IAT | 12 | 64 | 91 | 25 | 33 | 420 |
(106) | Single | IAT | 75 | 65 | 75 | 13 | 56 | 300 |
(118) | Single | IAT, AS | 24 | 58 | 83 | 25 | 50 | – |
(72) | Multi | IAT | 106 | 62 | 70 | 33 | 41 | 330 |
(14) | Single | IAT | 20 | 62 | 85 | 15 | 45 | 300 |
(111) | Single | IVT, IAT, ET | 91 | 65 | 89 | 32 | 42 | 396 |
(46) | Multi | IAT, ES, AS | 25 | 67 | 60 | 8 | 68 | 298 |
(64) | Multi | IVT, ET, AS | 38 | 64 | 68 | 18 | 64 | 420 |
(33) | Single | IVT, IAT, ET, AS | 59 | 70 | 76 | 39 | 14 | – |
(154) | Single | IAT, AS | 50 | – | – | – | 40 | – |
Aggregate | 46 | 64 | 78 | 27 | 46 | 394 | ||
|
Technologic endovascular advances have increased the feasibility of mechanical thrombectomy. There is robust evidence of its usefulness in the treatment of acute internal carotid artery and middle cerebral artery occlusion, leading to its recommendation in the treatment of these patients (116). Comparable data about its application to the treatment of basilar artery occlusion are scant.
Only 4 patients of 414 patients randomized in the mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRombectomie des Artères CErebrales [THRACE]) trial and 6 of 202 patients randomized in the Tenecteplase versus Alteplase before Endovascular Therapy for Ischemic Stroke (EXTEND-IA TNK) trial had basilar artery occlusion (29). However, many single-center and a few multicenter groups have published their experiences with these techniques (Table 3). A general overview of these reports suggests that mechanical thrombectomy improves recanalization success defined as thrombolysis in cerebral infarction (TICI, score = 2b – 3) and favorable neurologic outcome defined as modified Rankin scale = 0 – 2 while reducing 90-day mortality. However, such conclusions should be tempered given the heterogeneity of techniques embedded within these reports.
Reference | Series Type | Treatment Modalities | Patients (n) | Mean Age (years) | Recanalizationa (%) | Favorable outcomeb,c (%) | Mortalityc (%) | Treatment Time (min) |
(115) | Single | IVT, ET | 16 | 61 | 94 | 44 | 25 | 276 |
(105) | Single | IVT, ET | 36 | 71 | 67 | 31 | 36 | 237 |
(47) | Single | ET, AS | 18 | 68 | 94 | 50 | 22 | 6.1 |
(112) | Single | IVT, ET | 12 | 64 | 81 | 56 | 8 | 348 |
(28) | Single | IVT, ET | 78 | 68 | 30 | 45 | 9 | 240 |
(08) | Single | IAT, ET, AS | 28 | – | 64 | 57 | 21 | – |
(101) | Multi | IVT, IAT, ET, AS | 14 | 65 | 100 | 29 | 36 | 414 |
(100) | Single | IVT, IAT, ET, AS | 24 | 70 | 88 | 33 | 29 | 254 |
(46) | Multi | ES, AS | 32 | 68 | 88 | 22 | 25 | 282 |
(102; 103) | Single | IVT, ET | 31 | 61 | 74 | 35 | 32 | 357 |
(13) | Single | IVT, IAT,ET, AS | 25 | 68 | 96 | 50 | 12 | 285 |
(133) | Multi | IVT, IAT, ET | 148 | 71 | 79 | 34 | 35 | – |
(146) | Single | IAT, ET, AS | 18 | 60 | 94 | 33 | 28 | 194 |
(32) | Single | IVT, ET, AS | 24 | 57 | 63 | 21 | 33 | – |
(148) | Single | IVT, IAT, ET, AS | 14 | 62 | 86 | 29 | 50 | 562 |
(134) | Single | IVT, ET | 12 | 63 | 92 | 75 | 16 | 211 |
(42) | Multi | IVT, IAT, ET, AS | 72 | 59 | 94 | 36 | 32 | 300 |
(157) | Single | IVT, IAT, ET, AS | 50 | 71 | 96 | 54 | 12 | 306 |
(57) | Single | IVT, ET | 32 | 64 | 88 | 41 | 25 | 463 |
(143) | Single | IVT, IAT, ET | 38 | 58 | 89 | 50 | 39 | 288 |
(04) | Multi | IVT, ET, AS | 52 | 64 | 75 | 40 | 33 | 312 |
(43) | Single | IAT, ET, AS | 21 | 58 | 95 | 38 | 33 | – |
(69) | Single | IVT, IAT, ET, AS | 36 | 59 | 94 | 28 | 31 | 450 |
(72) | Single | IVT, IAT, ET, AS | 33 | 68 | 88 | 39 | 15 | 345 |
(83) | Single | ET, AS | 62 | 70 | 97 | 53 | 16 | 290 |
(48) | Single | IVT, ET | 34 | 62 | 50 | 32 | 29 | 375 |
(149) | Single | IVT, ET, AS | 19 | 62 | 90 | 53 | 5 | – |
(150) | Single | IVT, ET, AS | 22 | 61 | 91 | 41 | 41 | 257 |
(132) | Single | IVT, IAT, ET, AS | 51 | 72 | 80 | 26 | – | – |
(87) | Single | IVT, IAT, ET, AS | 68 | 58 | 90 | 46 | 28 | 395 |
(25) | Multi | IVT, IAT, ET, AS | 214 | 64 | 88 | 27 | 47 | 621 |
(60) | Multi | IVT, ET | 100 | 65 | 79 | 37 | 44 | 315 |
Aggregate | 45 | 62 | 84 | 40 | 26 | 322 | ||
|
The Basilar Artery Occlusion Endovascular Intervention versus Standard Medical Treatment (BEST) trial was a multicenter, randomized, open-label trial conducted between 2015 and 2017 (90). It randomized 131 patients with basilar artery occlusion within 8 hours of symptom onset to endovascular thrombectomy plus standard medical therapy (n=66) or standard medical therapy alone (n=65). The primary outcome was a modified Rankin scale score of 3 or lower at 90 days. The trial was terminated early due to poor recruitment and a high crossover rate. In the intention-to-treat analysis, there was no statistically significant difference in the primary outcome (42% in the intervention group vs. 32% in the control group; OR 1.74; 95% CI 0.81 to 3.74). The primary safety outcome was 90-day mortality and did not differ between groups. The trial was underpowered due to its early termination.
The BASICS Study Group conducted a prospective randomized trial of endovascular thrombectomy within 6 hours of symptom onset for stroke due to basilar artery occlusion (81). The trial was conducted between 2011 and 2019 in 23 centers in 7 countries and randomized 300 patients to standard medical care or endovascular thrombectomy. Most patients in each group received IV thrombolysis. The primary outcome was a modified Rankin Scale score of 0-3 at 90 days and occurred in 44.2% in the endovascular thrombectomy group and in 37.7% in the medical care group, a difference that was not statistically significant (RR 1.18; 95% CI 0.92 to 1.50). Symptomatic intracranial hemorrhage occurred in 4.5% in the endovascular thrombectomy group and in 0.7% in the medical therapy group (RR 6.9; 95% CI 0.9 to 53.0).
There are important caveats when interpreting the results from BEST and BASICS. In both trials, results may have been confounded by the loss of equipoise over the course of the trial period due to positive results from thrombectomy trials in the anterior circulation. This likely led to selection bias, with patients more likely to benefit from endovascular thrombectomy receiving treatment outside of the trial. This resulted in low recruitment and high crossover between groups. For example, of the 424 eligible patients screened in BASICS, 29% (n=124) were not enrolled, and 79% (n=98) of these patients received endovascular thrombectomy; the outcomes in these patients are not known (81). Neither trial used perfusion imaging for patient selection. Whether perfusion imaging would better identify patients who could potentially benefit from endovascular thrombectomy is unknown.
Taken together, the data for endovascular thrombectomy in basilar artery occlusion are inconclusive. However, the following takeaways can be justified: (a) arterial recanalization is most successfully achieved by endovascular thrombectomy (75% to 80%), and (b) arterial recanalization results in lower mortality (25% to 48%) and better neurologic outcome (ie, mRS 0-2 in approximately 33% to 43%) (77; 60).
Several factors have been studied as predictors of the outcome of therapeutic recanalization of basilar artery occlusion, including: (a) clinical severity, (b) topography of basilar artery occlusion, (c) angioarchitecture, (d) concurrent tandem vertebral artery occlusive pathology, (e) underlying in situ basilar artery atherostenosis, (f) clot burden, (g) recanalization technique, and (h) time to treatment.
Clinical severity. Patients with tandem proximal dominant vertebral artery occlusive lesions more commonly present with higher NIHSS scores and impaired consciousness (33). A more severe presenting syndrome has been consistently associated with worse outcomes, even in patients who undergo successful recanalization (10; 72; 42; 69; 25; 87). In particular, coma on presentation has been implicated in worse outcome (111; 69; 154).
Topography of basilar artery occlusion. Traditionally, basilar artery occlusion has been categorized into 3 distinct locations: proximal, middle, and distal. These categories correspond to a span of approximately one third the basilar artery length. Patients with distal basilar artery occlusion have been reported to have better prognosis following intraarterial thrombolysis or thrombectomy than patients with proximal or mid-basilar occlusion (35; 149). At least in part, this may be due to distal basilar artery occlusion more commonly resulting from embolism than in situ atherosclerosis.
Angioarchitecture. The most common anatomic variable is collateral circulation, which has been independently shown to positively influence both recanalization and outcomes when present (118; 133). However, in a series of 38 patients treated with first-generation thrombectomy devices, there was no demonstrable effect of unilateral hypoplasia of either the vertebral or posterior communicating arteries (64).
Tandem vertebral artery pathology. Concurrent tandem stenosis or occlusion of the dominant vertebral artery negatively influences outcomes in patients with basilar artery occlusion by reducing the chances of recanalization possibly related to prolonged procedural time and increased complexity (33). However, successful endovascular reconstruction of vertebral artery occlusion prior to basilar artery thrombectomy has been reported, with 66% of patients having favorable outcomes (45).
Underlying in situ basilar artery atherostenosis. The presence of an underlying atherosclerotic stenosis has been reported in 20% to 80% of patients with basilar artery occlusion (101; 43; 69; 82), particularly in the proximal segment, but it does not seem to negatively affect either outcome or rate success rate of recanalization (82). However, it commonly requires angioplasty with or without stenting (101; 69; 82).
Clot burden. Treatment with intravenous tPA is hampered by increased clot burden (139). However, reports regarding the impact of clot burden on endovascular treatment effectiveness have been conflicting (57; 132).
Recanalization technique. A major constraint in interpreting the existing literature on basilar artery recanalization is the heterogeneity of techniques reported. Despite this limitation, the following conclusions are derived. Patients receiving intraarterial treatment after pharmacologic thrombolysis may have higher recanalization rates (106; 111). These include not only thrombolytic agents but also glycoprotein IIb/IIIa receptor inhibitors (106; 111), although the literature regarding the use of the latter is scant. Thrombectomy, by either catheter aspiration (46; 60) or stent-retrievers (133) or both, is the preferred method of endovascular treatment (16).
Time to treatment. Elapsing time to recanalization likely adversely impacts patients with basilar artery occlusion as it does in other vascular territories. Although earlier recanalization has been associated with good outcome (10; 112; 13; 42; 69), this finding is not uniform across the literature (87). This is not surprising, considering the results of multicenter studies showing benefit of mechanical thrombectomy in selected patients with internal carotid or middle cerebral artery occlusion despite prolonged therapeutic windows (02; 107). There is evidence that patients who present without early radiographic evidence of extensive ischemic injury (eg, pc-ASPECTS score of 8 or higher), can be successfully treated up to 48 hours after onset (138). Conversely, radiographic evidence of extensive infarction constitutes a poor prognostic sign (138; 157). Moreover, studies employing multimodal MRI have shown salvage of diffusion-perfusion mismatch zones following intraarterial thrombolysis for acute basilar artery occlusion (109). Good outcomes were reported in 8 of 9 patients with prolonged basilar artery occlusion (median = 31 hours) selected for endovascular treatment on the basis of clinical-diffusion mismatch when the latter did not involve the dorsal pons, midbrain, or thalamus (88).
In addition, higher mortality or worse neurologic outcome have been associated with older age (72), male sex (111), diabetes mellitus (72), and tobacco smoking (25).
The optimal antithrombotic medication regimen for patients with basilar artery occlusion largely depends on the urgent recanalization strategy utilized and its outcome. In general, all antithrombotic medication should be avoided for 24 hours following treatment with intravenous tPA (116). However, patients treated with mechanical thrombectomy only have no restrictions to immediate postprocedural antithrombotic agents. Patients whose urgent recanalization treatment included stenting of an underlying atherosclerotic lesion constitute a subset whose treatment must include dual antiplatelet therapy to prevent in-stent thrombosis. The optimal duration of this treatment is uncertain, but a minimum of 6 weeks is reasonable.
In patients with high-risk sources of recurrent embolism (eg, atrial fibrillation, left apical thrombus, left atrial thrombus), anticoagulation should be considered to reduce the risk of additional cerebral embolization. However, anticoagulation may need to be delayed in situations where imaging shows evidence of hemorrhagic transformation or a large infarct volume (73).
Stroke progression due to in situ atherosclerosis may result from clot propagation occluding ostia of additional basilar artery branches or downstream embolism. In this setting, anticoagulation is often utilized although its effectiveness has not been established. Optimal antithrombotic medication selection for long-term secondary prevention therapy after initial basilar artery stroke is beyond the scope of the present review.
Neurosurgical intervention by posterior fossa decompression can be lifesaving when basilar artery strokes produce large cerebellar infarcts with mass effect that lead to obstructive hydrocephalus and cerebellar herniation, with or without brainstem compression (21).
Management of dolichoectasia of the basilar artery is challenging. On one hand, long-term antithrombotic therapy is theoretically attractive as a means to prevent progressive thrombosis in low-flow regions within patulous vessels (44). On the other, extreme caution regarding anticoagulation is urged by occasional observations of fatal subarachnoid hemorrhage (114; 18). Surgical treatments carry considerable risk because of the vulnerability of small pontine penetrators to injury, but should be considered when the vessel is compressing brainstem and cranial nerve structures. Surgical techniques include proximal vessel occlusion, or direct thrombectomy and reconstruction of the vessel lumen with clips (09).
Basilar artery stroke in children. This constitutes a rare event and, given the infrequency and atypical presentations depending on the child’s developmental age, stroke diagnosis is often delayed. Initial misdiagnosis as migraine or seizures is common. Additionally, stroke etiologic factors commonly found in adults such as atherosclerosis and atrial fibrillation are unlikely causes of childhood stroke, and the differential etiologic diagnosis is diverse. Cervicocephalic arterial dissection, congenital and acquired heart and vascular disorders, prothrombotic states, infections, and metabolic disorders must be considered.
Compared with adults, children with basilar artery strokes with basilar artery occlusion may have better long-term outcomes than adults with and without acute recanalization treatment (80; 34). Unfortunately, the Thrombolysis in Pediatric Stroke (TIPS) trial, an international, multicenter, phase 1, dose-finding study of intravenous tissue plasminogen activator in children 2 to 17 years of age terminated early due to slow recruitment (05). Case reports and small series have shown successful recanalization and neurologic outcome in children with basilar artery thrombosis treated with intravenous tPA (147; 120; 119) and endovascular strategies including bridging and thrombectomy (50).
No information specifically addresses the risk of basilar artery stroke in pregnancy or its treatment. Presumably, the risk is slightly increased as for ischemic stroke in general. Exclusion of pregnant women from trials of acute stroke treatments limits therapeutic decision-making. However, given the potential morbidity and mortality from acute basilar artery occlusion in pregnant women, risks and benefits of acute reperfusion therapies pose medical and ethical considerations. On the basis of clinical trial protocols leading to intravenous tPA approval, guidelines previously listed pregnancy as a relative contraindication. However, available case series demonstrate clinical improvement after intravenous tPA use in pregnancy and continuance of pregnancy to normal gestation (38). Therefore, current guidelines state that intravenous tPA may be considered for stroke during pregnancy when the anticipated benefits outweigh the potential risks to the fetus (116).
Data on thrombectomy in pregnancy are extrapolated from patients with anterior circulation large-vessel occlusion. An analysis of 4590 patients from the National Inpatient Sample who received mechanical thrombectomy between 2015 and 2018 found that thrombectomy was safe and efficacious, with pregnant patients experiencing low rates of intracerebral hemorrhage and lower likelihoods of poor functional outcome (41). Potential short- and long-term effects on the fetus from ionizing radiation and contrast exposure are uncertain.
Although previous retrospective and post hoc analyses have reported an association between general anesthesia and worse clinical outcomes compared to conscious sedation in patients undergoing mechanical thrombectomy (01), several small single-center randomized controlled trials have failed to confirm this finding (127; 93). Individualization of anesthetic modality is reasonable in lieu of additional trial data (116).
All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.
Michael Teitcher MD
Dr. Teitcher of Loyola Medicine has no relevant financial relationships to disclose.
See ProfileJose Biller MD
Dr. Biller of the Stritch School of Medicine at Loyola University of Chicago has no relevant financial relationships to disclose.
See ProfileSteven R Levine MD
Dr. Levine of the SUNY Health Science Center at Brooklyn has no relevant financial relationships to disclose.
See ProfileNearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Stroke & Vascular Disorders
Mar. 09, 2023
Stroke & Vascular Disorders
Mar. 09, 2023
Stroke & Vascular Disorders
Mar. 09, 2023
Stroke & Vascular Disorders
Mar. 09, 2023
Stroke & Vascular Disorders
Mar. 09, 2023
Stroke & Vascular Disorders
Feb. 02, 2023
Stroke & Vascular Disorders
Jan. 18, 2023
Stroke & Vascular Disorders
Jan. 18, 2023